Clinical Trials on Current Depressive Episode in France

Total 876 results

Etablissement Français du Sang
University Hospital, Grenoble

Completed

Evaluation of the Efficiency of Hydration by Isotonic Solution in the Prevent of the Fainting Whole Blood Donors (EVASION)

Presyncope | Fainting | Syncopal Episode

France
Janssen Research & Development, LLC

Completed

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-2)

Treatment-resistant Depression

United States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
Institut National de la Santé Et de la Recherche...
Assistance Publique - Hôpitaux de Paris; European Commission; Fondation FondaMental

Completed

European Comparative Effectiveness Research on Internet-based Depression Treatment (E-COMPARED)

Depressive Disorder

France
COMPASS Pathways

Recruiting

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Treatment Resistant Depression

United States
University Hospital, Montpellier
Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire... and other collaborators

Unknown

Predictors of Suicidal Behavior in Depression (SECS)

Depression | Suicidal Behavior | Traumatic Events | Impulsivity Aggression

France
Centre Hospitalier St Anne

Completed

ATtention Test and Executive Functions After STroke to Predict Depression. (ATTEST-Depress)

Post-stroke Depression

France
Weprom
Kelindi

Completed

Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App

Development, Child | Postnatal Depression

France
CeNeRx BioPharma Inc.

Completed

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression (CX157-201)

Treatment Resistant Depression

United States
University Hospital, Toulouse

Recruiting

Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression (HUGS)

Post Partum Depression

France
Brainsway

Completed

Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder

Major Depressive Disorder

United States, Canada, Germany, Israel, France
Biogen

Completed

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

Major Depressive Disorder

United States
Neumora Therapeutics, Inc.

Recruiting

Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder

Major Depressive Disorder

United States, Canada
Sanofi

Completed

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Depressive Disorder

France, Canada, Germany, Portugal, Czech Republic, Mexico, Croatia, Chile
Centre Hospitalier de Troyes

Recruiting

Evaluation of Access to Screening for Post-partum Depression Via the Postnatal Interview Within 8 Weeks of Birth in Women Who Have Gave Birth at the Troyes Hospital ( DEPRESSIONPP ) (DEPRESSIONPP)

Depression, Postpartum

France
Janssen Research & Development, LLC

Terminated

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression

Depressive Disorder

Spain, France, Belgium, Netherlands
Eli Lilly and Company

Completed

A Study in Prevention of Re-emergence of Depression Symptoms

Major Depressive Disorder

United States, Germany, Italy, Turkey, Russian Federation, Korea, Republic of, Greece, France, Croatia, Romania, Spain, Argentina, Puerto Rico, Belgium, Mexico, Slovakia
Centre Psychothérapique de Nancy
Institut National de la Santé Et de la Recherche Médicale, France; BioSerenity

Recruiting

REtinal and VIsual Cortical Response in Early PSYchosis (REVIPSY)

Prodromal Schizophrenia | Prodromal Symptoms | Healthy Controls | Psychotic Episode

France
Avanir Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Depressive Disorder, Treatment-Resistant

United States
Centre Hospitalier of Chartres

Completed

Improve the Quality of Life After a Hospitalization in Critical Care (AQVAR)

Depression | Depression Symptoms

France
Relmada Therapeutics, Inc.

Recruiting

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (RELIANCE-II)

Depression | Major Depressive Disorder

United States
Institut de Recherche Biomedicale des Armees

Completed

Post-natal Depression and Chronic Stress (serene)

Depression, Postpartum

France
Bristol-Myers Squibb
Otsuka America Pharmaceutical

Completed

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Sunovion

Withdrawn

Major Depressive Disorder With Mixed Features (RESOLVE2)

Major Depressive Disorder

United States
Intra-Cellular Therapies, Inc.

Completed

Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder

Bipolar Depression | Major Depressive Disorder

United States, Bulgaria, Russian Federation, Serbia, Ukraine
Sanofi

Completed

A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder (AGATE)

Major Depression

Belgium, Canada, Chile, Estonia, Finland, France, Germany, Netherlands, Russian Federation, Slovakia, South Africa, Sweden
Groupe Hospitalier Paris Saint Joseph

Not yet recruiting

Genetic Risk Factors Predictive of the Occurrence of Maternally Diagnosed Perinatal Depression in Women (PsyCOVIDUMGEN)

Perinatal Depression

France
H. Lundbeck A/S

Completed

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Depressive Disorder, Major

Spain, Hungary, Russian Federation, Bulgaria, Estonia, France, Germany, Italy, Latvia, Poland, Serbia, South Africa, United Kingdom
Institut Rosell Lallemand
BioFortis

Completed

Study of the Effects of Probiotics Upon Infectious Episodes in Subject Aged More Than 60, During Winter.

Infectious Episodes (ENT, Gastro-intestinal and Pulmonary)

France
Weprom
Kelindi

Completed

Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study (MALO_2)

Post Partum Depression | Child Development Disorder

France
University Hospital, Clermont-Ferrand

Completed

Identification of the Best Self-questionnaire to Diagnose Depression in Patients With Psoriasis (DePsoVal) (DePsoVal)

Depression | Psoriasis

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder

Depressive Disorder, Major

Finland, France, South Africa, Estonia, Croatia, Lithuania, Latvia, Slovakia, Poland, Romania
Pfizer

Completed

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Major Depressive Disorder

United States, Chile, Mexico
Biogen

Terminated

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

Major Depressive Disorder

United States
Relmada Therapeutics, Inc.

Recruiting

Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD (RELIGHT)

Depression | Major Depressive Disorder

United States
Pfizer

Completed

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Major Depressive Disorder

United States, Mexico
AbbVie

Completed

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Canada, Czechia, Finland, Poland, Puerto Rico, Serbia, Slovakia
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

MDD

United States
University Hospital, Strasbourg, France

Not yet recruiting

Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients (BKV-Pneumo)

Graft Rejection | Renal-urinary Impairment | Infection Episodes

France
Hospital de Clinicas de Porto Alegre

Completed

Exercise and Severe Depression: Clinical and Biological Analysis

Depression

Brazil
Biogen

Completed

A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Praxis Precision Medicines

Completed

A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder

Major Depressive Disorder

United States, Australia
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
Forest Laboratories

Completed

Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Eli Lilly and Company

Completed

A Study in the Treatment of Children and Adolescents With Major Depressive Disorder

Major Depressive Disorder

United States, Germany, Russian Federation, South Africa, France, Ukraine, Slovakia
Hoffmann-La Roche

Completed

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Major Depressive Disorder

Germany, United States, Taiwan, Mexico, Poland, Russian Federation, Chile, Japan, Romania
Sage Therapeutics
Biogen

Completed

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Forest Laboratories

Completed

Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, Canada
GlaxoSmithKline

Terminated

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder (Orvepitant MDD)

Depressive Disorder

United States, Canada
Pfizer

Completed

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Major Depressive Disorder

United States, Chile

Clinical Trials on Current Depressive Episode in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations